Jamieson Wellness Inc. Reports First Quarter 2023 Results, Maintains Full Year Outlook and Declares First Quarter Dividend Life Science Investing
Jamieson Wellness Inc. Completes Previously Announced Distributor Transaction in China Life Science Investing
CHMP Adopts Positive Opinion Recommending Hepcludex® for Full Marketing Authorization for the Treatment of Hepatitis Delta Virus Life Science Investing
Aurinia Pharmaceuticals Reports First Quarter 2023 Financial and Operational Results Life Science Investing
Johnson & Johnson and Kenvue Announce Pricing of Upsized Kenvue Inc. Initial Public Offering Pharmaceutical Investing
COMPASS Pathways plc to announce first quarter 2023 financial results on 11 May 2023 Psychedelics Investing
